Lantern Pharma (LTRN) Stock Price
Lantern Pharma Price
Lantern Pharma stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Lantern Pharma business model & stock analysis
Frequently asked questions about Lantern Pharma
8 analysts currently rate the Lantern Pharma stock: 7 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the Lantern Pharma share trades at 0.47 EUR (0.52 USD).
The Lantern Pharma share (LTRN) is listed on 1 stock exchanges, including: NASDAQ (LTRN).
The revenue cannot currently be calculated for Lantern Pharma.
The expected profit of Lantern Pharma is -16.88 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Lantern Pharma is currently -0.34. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Lantern Pharma stock.
The P/S cannot be calculated for Lantern Pharma currently.
The Eulerpool Quality Score for Lantern Pharma is 2/10.
The ISIN of Lantern Pharma is US51654W1018. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Lantern Pharma is A2P5NM. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Lantern Pharma is LTRN. The ticker symbol is used to trade Lantern Pharma shares on the stock exchange.
Lantern Pharma stock
Lantern Pharma Peer Group
Lantern Pharma Ticker
Lantern Pharma FIGI
All fundamentals and in-depth analysis of Lantern Pharma
Our stock analysis for Lantern Pharma stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Lantern Pharma. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.